← Back to Analyst Consensus 
CLS Buy
CELESTICA INC
Current Price —
Implied Upside —
Analysts 14
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 30, 2026 | Bernstein | initiate | — → Outperform | — | 52% |
| Sep 15, 2026 | FBN Securities | initiate | — → Outperform | — | — |
| Aug 24, 2026 | UBS | upgrade | Neutral → Buy | — | 54% |
| Aug 7, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jul 29, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Jul 29, 2026 | Wolfe Research | maintain | Outperform → Outperform | — | 53% |
| Jul 29, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 1, 2026 | Rothschild & Co | initiate | — → Buy | — | 56% |
| Apr 29, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Apr 29, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Apr 29, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Apr 29, 2026 | TD Cowen | upgrade | Hold → Buy | — | 54% |
| Apr 29, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Apr 29, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Apr 29, 2026 | Susquehanna | maintain | Positive → Positive | — | 55% |
| Apr 24, 2026 | BMO Capital | maintain | Outperform → Outperform | — | 53% |
| Apr 20, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| Apr 20, 2026 | TD Cowen | maintain | Hold → Hold | — | 54% |
| Apr 16, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Mar 11, 2026 | CIBC | maintain | Outperformer → Outperformer | — | 64% |
| Jan 30, 2026 | Citigroup | maintain | Buy → Buy | $338 | 54% |
| Jan 30, 2026 | Barclays | maintain | Overweight → Overweight | $391 | 53% |
| Dec 1, 2025 | Goldman Sachs | maintain | Buy → Buy | $440 | 54% |
| Nov 14, 2025 | Barclays | maintain | Overweight → Overweight | $359 | 53% |
| Nov 10, 2025 | Citigroup | upgrade | Neutral → Buy | $375 | 54% |
| Oct 29, 2025 | CIBC | maintain | Outperformer → Outperformer | $400 | 64% |
| Oct 29, 2025 | TD Securities | maintain | Hold → Hold | $305 | 54% |
| Oct 29, 2025 | Goldman Sachs | maintain | Buy → Buy | $440 | 54% |
| Oct 29, 2025 | UBS | maintain | Neutral → Neutral | $350 | 54% |
| Oct 29, 2025 | Stifel | reiterate | Buy → Buy | $385 | 53% |
| Oct 29, 2025 | RBC Capital | maintain | Outperform → Outperform | $400 | 55% |
| Oct 29, 2025 | JP Morgan | maintain | Overweight → Overweight | $360 | 54% |
| Oct 29, 2025 | Barclays | maintain | Overweight → Overweight | $357 | 53% |
| Oct 22, 2025 | RBC Capital | maintain | Outperform → Outperform | $315 | 55% |
| Oct 20, 2025 | CIBC | maintain | Outperformer → Outperformer | $315 | 64% |
| Oct 16, 2025 | Goldman Sachs | initiate | — → Buy | $340 | 54% |
| Oct 3, 2025 | TD Securities | downgrade | Buy → Hold | $238 | 54% |
| Sep 8, 2025 | JP Morgan | maintain | Overweight → Overweight | $295 | 54% |
| Aug 19, 2025 | CICC | initiate | — → Outperform | $0 | 59% |
| Jul 30, 2025 | Citigroup | maintain | Neutral → Neutral | $212 | 54% |
| Jul 30, 2025 | UBS | maintain | Neutral → Neutral | $208 | 54% |
| Jul 30, 2025 | RBC Capital | maintain | Outperform → Outperform | $225 | 55% |
| Jul 30, 2025 | Barclays | maintain | Overweight → Overweight | $220 | 53% |
| Jul 30, 2025 | Canaccord Genuity | maintain | Buy → Buy | $240 | 48% |
| Jul 21, 2025 | Citigroup | initiate | — → Neutral | $172 | 54% |
| Jul 17, 2025 | JP Morgan | maintain | Overweight → Overweight | $170 | 54% |
| Jun 11, 2025 | Barclays | maintain | Overweight → Overweight | $146 | 53% |
| May 22, 2025 | BMO Capital | maintain | Outperform → Outperform | $130 | 53% |
| Apr 29, 2025 | Argus Research | maintain | Buy → Buy | $120 | 53% |
| Apr 28, 2025 | RBC Capital | reiterate | Outperform → Outperform | $120 | 55% |
Price Target Trend
Jul 1, 2026 Oct 26, 2026
EPS Estimates
0q —
0y —
+1q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days